您好, 歡迎來到儀表網(wǎng)! 登錄| 免費(fèi)注冊(cè)| 產(chǎn)品展廳| 收藏商鋪|
當(dāng)前位置:上海博研生物科技有限公司>>科研抗體>>一抗>> 鈣粘蛋白相關(guān)的神經(jīng)受體1抗體,Anti-CNR1/CB1抗體
參 考 價(jià) | 面議 |
產(chǎn)品型號(hào)
品 牌
廠商性質(zhì)生產(chǎn)商
所 在 地上海市
聯(lián)系方式:張景查看聯(lián)系方式
更新時(shí)間:2018-04-02 10:45:19瀏覽次數(shù):380次
聯(lián)系我時(shí),請(qǐng)告知來自 儀表網(wǎng)F肌動(dòng)蛋白α1亞基抗體,Anti-CAPZA1抗體
細(xì)胞表面趨化因子受體2抗體,Anti-CXCR2抗體
“鈣粘蛋白相關(guān)的神經(jīng)受體1抗體,Anti-CNR1/CB1抗體”應(yīng)用于IHC、WB、 IF、IP、ELISA,質(zhì)量保證,無效免費(fèi)退換,另外本公司生產(chǎn)經(jīng)營各種標(biāo)記二抗、免疫印跡常用試劑、免疫組化常用試劑,咨詢!
產(chǎn)品介紹:
【產(chǎn)品名稱】:鈣粘蛋白相關(guān)的神經(jīng)受體1抗體,Anti-CNR1/CB1抗體
【產(chǎn)品類型】:一抗
【產(chǎn)品編號(hào)】:BYk-1683R
【相關(guān)標(biāo)記】: HRP Biotin Gold RBITC AP FITC Cy3 Cy5 Cy5.5 Cy7 PE PE-Cy3 PE-CY5 PE-CY5.5 PE-CY7 APC Alexa Fluor 350 Alexa Fluor 488 Alexa Fluor 555 Alexa Fluor 647
【性 狀】: Lyophilized or Liquid
【濃 度】: 1mg/1ml
【亞 型】: IgG
【規(guī) 格】:0.1ml/100ug,0.2ml/200ug
【抗體來源】: Rabbit OR MOUSE
【克隆類型】: polyclonal or monoclonal
【產(chǎn)品用途】:科研實(shí)驗(yàn),用于免疫組化實(shí)驗(yàn),WB實(shí)驗(yàn)、IF、IP、ELISA實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,F(xiàn)ITC標(biāo)記,BIO等。
【貯 存】: Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
【詳細(xì)信息】: Cannabinoid Receptor 1 is one of two main cannabinoid receptors which are G-protein-coupled receptors inhibiting adenylate cyclase activity. The CB(1) receptor is densely distributed in areas of the brain related to motor control, cognition, emotional responses, motivated behaviour and homeostasis. Cannabinoid receptors have a complex molecular architecture that allows a single receptor to recognize multiple classes of compounds and produce an array of distinct downstream effects.
Recent pharmacological advances have led to the synthesis of cannabinoid receptor agonists and antagonists. This has helped in the development of new strategies for the treatment of pain, obesity, neurological diseases including multiple sclerosis, emotional disturbances such as anxiety and other psychiatric disorders including drug and alcohol addiction.
鈣粘蛋白相關(guān)的神經(jīng)受體1抗體,Anti-CNR1/CB1抗體【相關(guān)產(chǎn)品】:
Anti-KLHL30抗體,Kelch樣蛋白30抗體
Anti-KLHL4抗體,Kelch樣蛋白4抗體
Anti-KLKP1抗體,*相關(guān)蛋白抗體
Anti-KLRA1抗體,KLRA1蛋白抗體
Anti-KLRA2抗體,KLRA2蛋白抗體
Anti-KLRA3/Ly49C抗體,自然殺傷細(xì)胞凝集素樣受體3抗體
Anti-KLRAQ/CCDC128抗體,卷曲螺旋結(jié)構(gòu)域蛋白128抗體
Anti-KLRC3抗體,殺傷細(xì)胞凝集素樣受體C亞家族成員3抗體
Anti-KLRC4抗體,殺傷細(xì)胞凝集素樣受體C亞家族成員4抗體
Anti-KLRF1抗體,殺傷細(xì)胞凝集素樣受體F1抗體
Anti-KLRF2抗體,殺傷細(xì)胞凝集素樣受體F2抗體
Anti-KLRG1抗體,自然殺傷凝集素樣受體F2抗體
Anti-KLRG2抗體,自然殺傷凝集素樣受體G2抗體
Anti-KMT1B抗體,賴氨酸N甲基轉(zhuǎn)移酶1B抗體
Anti-KMT1D抗體,賴氨酸N甲基轉(zhuǎn)移酶1D/EHMT1抗體
請(qǐng)輸入賬號(hào)
請(qǐng)輸入密碼
請(qǐng)輸驗(yàn)證碼
以上信息由企業(yè)自行提供,信息內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由相關(guān)企業(yè)負(fù)責(zé),儀表網(wǎng)對(duì)此不承擔(dān)任何保證責(zé)任。
溫馨提示:為規(guī)避購買風(fēng)險(xiǎn),建議您在購買產(chǎn)品前務(wù)必確認(rèn)供應(yīng)商資質(zhì)及產(chǎn)品質(zhì)量。